Related Experiment Videos
Disruption of Ixodes scapularis anticoagulation by using RNA interference.
Sukanya Narasimhan1, Ruth R Montgomery, Kathleen DePonte
1Sections of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Summary
Targeting tick anticoagulant Salp14 with vaccines could prevent diseases transmitted by Ixodes scapularis. Silencing Salp14 reduced tick feeding and anticoagulant activity, identifying potential vaccine targets.
Area of Science:
- Vector-borne disease research
- Molecular biology of arthropod vectors
- Vaccine development against infectious agents
Background:
- Ixodes scapularis ticks transmit pathogens like Borrelia burgdorferi.
- Vaccines targeting tick proteins could prevent disease transmission during feeding.
- Salp14 is a key anticoagulant protein in I. scapularis saliva.
Purpose of the Study:
- To investigate the role of Salp14 in tick feeding and anticoagulant activity.
- To assess the potential of Salp14 as a vaccine target against tick-borne diseases.
- To demonstrate the efficacy of RNA interference in silencing I. scapularis genes.
Main Methods:
- RNA interference (RNAi) was used to silence Salp14 and its paralogs in I. scapularis.
- Quantitative analysis of Salp14 mRNA and protein levels to confirm gene silencing.
- Assay of anticoagulant activity in tick salivary glands (anti-factor Xa activity).
- Measurement of tick engorgement weights to assess feeding efficiency.
Main Results:
- RNAi successfully reduced Salp14 mRNA and protein expression.
- Salivary glands lacking Salp14 showed a 60-80% reduction in anti-factor Xa activity.
- Silencing Salp14 and its paralogs decreased I. scapularis engorgement weights by 50-70%.
- Multiple anticoagulants likely need simultaneous ablation to completely inhibit tick feeding.
Conclusions:
- Salp14 plays a significant role in I. scapularis anticoagulant activity and feeding.
- RNA interference is a viable tool for disrupting I. scapularis gene function in vivo.
- Salp14 and its paralogs represent promising vaccine candidates for controlling tick-borne diseases.